Blood Pressure Changes Linked to Poor Brain Health in Late Adulthood


Findings from the Insight 46 study reveal blood pressure changes during midlife can lead to poorer brain health as a patient gets older.

Professor Jonathan Schott

Professor Jonathan Schott

Results of a recent life-long study, performed by investigators at the University College London, suggest there may be a link between changes in blood pressure early in life to poorer brain health as a person ages.

Insight 46, which is the oldest running birth cohort study in Britain, revealed high and increasing blood pressure from early adulthood into midlife appeared to be associated with increases in white matter hyperintensity volume (WMHV) and smaller brain volumes between the ages of 69 and 71 years old.

"We now know that damage caused by high blood pressure is unlikely to be driven through the hallmark Alzheimer's protein amyloid, but through changes in blood vessels and the brain's architecture,” said Jonathan Schott, professor at University College London. “The findings show that blood pressure monitoring and interventions aimed at maximizing brain health later in life need to be targeted at least by early midlife."

Insight 46, which was a substudy of the Medical Research Council National Survey of Health and Development, contained 502 participants who were followed from their birth in during the same week 1946. All participants had their blood pressure assessed at the ages of 36, 43, 53, 60 to 64, and 69 years old.

Additionally, 465 participants in the study underwent brain scans to assess their brain health. Of the 465 who underwent brain scans, 238 were men, the mean age of the group was 70.7 years, and 18% (83) were amyloid-β-positive.

Upon analyses, investigators found that higher systolic blood pressure and diastolic blood pressure at all timepoints were associated with greater WMHV but the association only reached significance after the age of 53.

In a fully-adjusted model, investigators found a 10 mm Hg increase in systolic blood pressure at 53 years of age was associated with a relative increase in mean WMHV of 7% (relative increase 1.07, 95% CI 1.01—1.24, P = 0.024). Additionally, a 10 mm Hg in tease in diastolic blood pressure at 53 years of age was associated with a 15% increase (1.15, 1.04 – 1.27, P = 0.0057) in mean WMHV.

Higher diastolic blood pressure at age 43 was associated with smaller whole-brain volume at 69 to 71 years (—6.9 mL per 10 mm Hg increase, –11.9 to –1.9, P = 0.0068). Investigators noted that greater increases in Diastolic blood pressure between 36 and 43 years of age were also associated with smaller whole-brain volume (–6.5 mL per 1 SD change, –11.1 to –1.9, P = 0.0054). Investigators also added that absolute blood pressure nor change in blood pressure predicted amyloid-β status at 69 to 71 years.

“The Insight 46 study has allowed us to reveal more about the complex relationship between blood pressure and brain health,” Schott said. “The findings suggest that blood pressure even in our 30s could have a knock-on effect on brain health four decades later.”

This study, “Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study,” was published online in The Lancet Neurology.

Related Videos
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
Video 6 - "Evaluating Safety of Novel LDL Management Mechanism"
Video 5 - "Optimizing PCSK9 Inhibitors and Analyzing Plaque Reduction Data"
Etienne Sibille, PhD: Innovations in Cognitive Pathology
Video 4 - "Innovations in Small Interfering RNA (siRNA) Therapy"
© 2024 MJH Life Sciences

All rights reserved.